- Nada Wigand
Pathology Grand Rounds offers a diverse range of educational opportunities in clinical and anatomic pathology. Examples include new technology in diagnostic laboratories, advanced diagnostic algorithms, and data storage, retrieval, and analytical tools. Image analysis, artificial intelligence, and block-chain technology are recent examples. Experimental advances in disease pathogenesis, emerging trends in laboratory-based health management, quality systems, and educational methods are among topics.
MD/DO, and Students
|Thomas Raife, MD, Chair||Nada Wigand, Coordinator||Erik Ranheim, MD, PhD|
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity, all relevant financial relationships have been mitigated and detailed disclosures are listed below.
* Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Detailed disclosures will be available prior to the start of the activity.
Disclosures for Planning Committee
Patient Care and Procedural Skills
Practice-Based Learning and Improvement
Interpersonal and Communication Skills
DIVERSITY, EQUITY, AND INCLUSION COMPETENCIES
Address Health Disparities
Non-IP — Competence
As a result of participation in this educational series, members of the healthcare team will be able to:
- Identify emerging diagnostic schemes, disease classification schemes, technological advances, such as the principles of MALDI-TOF as it applies to the microbiology, in order to effectively manage cases.
- Identify appropriate technology, protocols and workflows in order to optimize the quality and accuracy of pathology services and diagnoses.
- Develop an appreciation of the roles and responsibilities of members of the interdisciplinary pathology team, particularly with regard to addressing health disparities.